Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 356

1.

CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma.

Khan A, Baker SP, Patwardhan NA, Pullman JM.

Virchows Arch. 1998 May;432(5):427-32.

PMID:
9645441
[PubMed - indexed for MEDLINE]
2.

Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.

Patel MR, Bryson PC, Shores CG, Hart CF, Thorne LB, Deal AM, Zanation AM.

Arch Otolaryngol Head Neck Surg. 2009 Jun;135(6):590-6. doi: 10.1001/archoto.2009.54.

PMID:
19528408
[PubMed - indexed for MEDLINE]
3.

Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.

Mai KT, Ford JC, Yazdi HM, Perkins DG, Commons AS.

Pathol Res Pract. 2000;196(8):533-40.

PMID:
10982016
[PubMed - indexed for MEDLINE]
4.

Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas.

Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G.

Endocr Pathol. 2001 Fall;12(3):275-9.

PMID:
11740048
[PubMed - indexed for MEDLINE]
5.

MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma.

Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T.

Mod Pathol. 2008 Sep;21(9):1139-46. doi: 10.1038/modpathol.2008.105. Epub 2008 Jun 27.

PMID:
18587330
[PubMed - indexed for MEDLINE]
Free Article
6.

Leu-7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms.

Ostrowski ML, Brown RW, Wheeler TM, Green LK, Schaffner DL.

Diagn Cytopathol. 1995 Jun;12(4):297-302.

PMID:
7544717
[PubMed - indexed for MEDLINE]
7.
8.

Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?

Unger P, Ewart M, Wang BY, Gan L, Kohtz DS, Burstein DE.

Hum Pathol. 2003 Aug;34(8):764-9.

PMID:
14506636
[PubMed - indexed for MEDLINE]
9.

Papillary thyroid carcinoma and related thyroid neoplastic lesions: a light microscopic study with emphasis on nuclear changes.

Mai KT, Yazdi HM, Perkins DG, Commons AS, Thomas J.

Tumori. 2000 May-Jun;86(3):238-49.

PMID:
10939606
[PubMed - indexed for MEDLINE]
10.

Can CD10 be used as a diagnostic marker in thyroid pathology?

Yegen G, Demir MA, Ertan Y, Nalbant OA, Tunçyürek M.

Virchows Arch. 2009 Jan;454(1):101-5. doi: 10.1007/s00428-008-0698-2. Epub 2008 Nov 25.

PMID:
19031085
[PubMed - indexed for MEDLINE]
11.

Diagnostic value of qualitative and quantitative variables in thyroid lesions.

Rout P, Shariff S.

Cytopathology. 1999 Jun;10(3):171-9.

PMID:
10390065
[PubMed - indexed for MEDLINE]
12.

Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.

El Demellawy D, Nasr AL, Babay S, Alowami S.

Pathol Res Pract. 2009;205(5):303-9. doi: 10.1016/j.prp.2008.11.011. Epub 2009 Jan 18.

PMID:
19153015
[PubMed - indexed for MEDLINE]
13.

Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.

Mehrotra P, Okpokam A, Bouhaidar R, Johnson SJ, Wilson JA, Davies BR, Lennard TW.

Histopathology. 2004 Nov;45(5):493-500.

PMID:
15500653
[PubMed - indexed for MEDLINE]
14.

The role of immunolocalization of CD57 and GLUT-1 in cell blocks in fine-needle aspiration diagnosis of papillary thyroid carcinoma.

Chandan VS, Faquin WC, Wilbur DC, Khurana KK.

Cancer. 2006 Oct 25;108(5):331-6.

PMID:
16944537
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression of the hepatocyte growth factor and c-met in normal thyroid, non-neoplastic, and neoplastic nodules.

Trovato M, Villari D, Bartolone L, Spinella S, Simone A, Violi MA, Trimarchi F, Batolo D, Benvenga S.

Thyroid. 1998 Feb;8(2):125-31.

PMID:
9510120
[PubMed - indexed for MEDLINE]
16.

CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis.

Anderson CE, Graham C, Herriot MM, Kamel HM, Salter DM.

Histopathology. 2009 Dec;55(6):683-6. doi: 10.1111/j.1365-2559.2009.03438.x. Epub .

PMID:
19922591
[PubMed - indexed for MEDLINE]
17.

Immunohistochemical separation of follicular variant of papillary thyroid carcinoma from follicular adenoma.

Nakamura N, Erickson LA, Jin L, Kajita S, Zhang H, Qian X, Rumilla K, Lloyd RV.

Endocr Pathol. 2006 Fall;17(3):213-23.

PMID:
17308358
[PubMed - indexed for MEDLINE]
18.

A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression.

Rosen J, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA, Libutti SK.

Surgery. 2005 Dec;138(6):1050-6; discussion 1056-7.

PMID:
16360390
[PubMed - indexed for MEDLINE]
19.

The investigation of galectin-3 in diseases of the thyroid gland.

Kovács RB, Földes J, Winkler G, Bodó M, Sápi Z.

Eur J Endocrinol. 2003 Nov;149(5):449-53.

PMID:
14585093
[PubMed - indexed for MEDLINE]
Free Article
20.

Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.

Ghali VS, Jimenez EJ, Garcia RL.

Hum Pathol. 1992 Jan;23(1):21-5.

PMID:
1371984
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk